- Home
- EIKN vs PRME Comparison
EIKN vs PRME Comparison
Compare EIKN & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$13.45
HOLD
Current Price
$3.36
Company Overview
Basic Information| Metric | EIKN | PRME |
|---|---|---|
| Founded | 2019 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 731.6M | 666.1M |
| IPO Year | 2026 | 2022 |
Fundamental Metrics
Financial Performance| Metric | EIKN | PRME |
|---|---|---|
| Price | $13.45 | $3.36 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $6.42 |
| AVG Volume (30 Days) | 1.6M | ★ 3.1M |
| Earning Date | 01-01-0001 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $5,977,000.00 |
| Revenue This Year | N/A | $95.64 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 647.13 |
| 52 Week Low | $13.30 | $1.11 |
| 52 Week High | $17.40 | $6.94 |
Technical Indicators
Market Signals| Indicator | EIKN | PRME |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 40.63 |
| Support Level | N/A | $3.21 |
| Resistance Level | N/A | $3.65 |
| Average True Range (ATR) | 0.00 | 0.31 |
| MACD | 0.00 | -0.08 |
| Stochastic Oscillator | 0.00 | 10.69 |
Price Performance
Historical Comparison EIKN
PRME
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.